Losartan
Losartan
Film-coated tablets 50 mg
ATC C09CA01Prescription Only Medicine
Medicines reimbursed by the Health Insurance Fund
POSOLOGY AND METHOD OF ADMINISTRATION
Method of administration: Losartan film-coated tablets should be swallowed with a glass of water. May be administered with or without food.
Special populations
Paediatric population
Use in the Elderly: Although consideration should be given to initiating therapy with 25 mg in patients over 75 years of age, dosage adjustment is not usually necessary for the elderly.
Medicine’s information on this web page is only a short description of its characteristics. Do not take them as recommendations for self-treatment of your health condition.
You must inform your physician and pharmacist and follow their recommendations before you use the medicine for treatment. Always read carefully the patient information leaflet.
COMPOSITION
Each film-coated tablet contains 50 mg losartan potassium, excipients. |
THERAPEUTIC INDICATIONS
– Treatment of essential hypertension in adults and in children and adolescents 6 – 18 years of age. – Treatment of renal disease in adult patients with hypertension and type 2 diabetes mellitus with proteinuria ≥ 0.5 g/day as part of antihypertensive treatment. – Treatment of chronic heart failure in adult patients when treatment with angiotensin-converting enzyme (ACE) inhibitors is not considered suitable due to incompatibility, especially cough, or contraindication. Patients with heart failure who have been stabilised with an ACE inhibitor should not be switched to losartan. The patients should have a left ventricular ejection fraction ≤ 40% and should be clinically stable and on an established treatment regimen for chronic heart failure. – Reduction in the risk of stroke in adult hypertensive patients with left ventricular hypertrophy documented by electrocardiography. |
CONTRAINDICATIONS
• Hypersensitivity to losartan potassium or to any of the excipients. • 2nd and 3rd trimester of pregnancy. • Severe hepatic impairment. • The concomitant use of losartan with aliskiren-containing products is contraindicated in patients with diabetes mellitus or renal impairment (GFR < 60 ml/min/1.73 m²). |
PACKAGING
Box with 30 film-coated tablets of 50 mg (3 blisters x 10 tablets) |
Recent Comments